Industry reports
Editor highlights

Search inside this page

All regions

Free Market Research Guides to Download

Drug and Medication Industry Market Research Reports, April 2014

You might be interested in: drug, vaccine, medicine, more »

» View Public Reports

1-44 of about 7 800 reports

Company Report: Drug and Medication for Year 2014

  • Company report
  • April 2014
  • 3 pages
  • by Governmental Agency

... Label use, no preslaughter withdrawal period is required for neonatal calves from treated cows regardless of colostrum consumption. Federal law restricts this drug to use by or on the order ...

  • Industries: Drug and Medication

Vaccine Sector Trends

  • Industry report
  • April 2014
  • 40 pages
  • by Intergovernmental Agency

... For ipv introduction ipv vaccine financing and supply unicef awarded a tender for ipv vaccines in february 2014, which makes sufficient quantities of affordable ipv available ipv pricing as of 28 ...

  • Industries: Drug and Medication

Company Report: Drug and Medication in Netherlands and Belgium for Year 2014

  • Company report
  • April 2014
  • 4 pages
  • Industries: Drug and Medication
  • Countries: Netherlands, Belgium

Company Report: Drug and Medication for Year 2014

  • Company report
  • April 2014
  • 4 pages
  • Industries: Drug and Medication

Vaccine Market in The United States and Sri Lanka

  • Industry report
  • April 2014
  • 44 pages
  • by Intergovernmental Agency

... Pediatrics 2011 *varicella as the underlying cause of death 1990-1994 to 2004-2007 88% decline overall 67% among 50+ 90% among 20-49 97% among ...

  • Industries: Drug and Medication
  • Countries: United States, World, Sri Lanka

Company Report: Drug and Medication for Year 2014

  • Company report
  • April 2014
  • 29 pages
  • Industries: Drug and Medication

PDL BioPharma Inc. - Company Report for Year 2014

  • Company report
  • April 2014
  • 2 pages
  • by Corporation

... In all other global markets. Kaleo expects to launch evzio in the us later this year. Evzio is approved for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and ...

  • Industries: Drug and Medication
  • Countries: United States, Canada, North America

Japan Tobacco Inc. - Company Report for Year 2014

  • Company report
  • April 2014
  • 2 pages

... As a result, operating income, ordinary income and net income are also expected to be higher than the previously announced forecast figures. (Reference) although drug prices were revised in april 2014 ...

  • Industries: Drug and Medication
  • Countries: Japan

The British Antibiotic Sector

  • Industry report
  • April 2014
  • 37 pages

... Research to have a major impact in reducing the burden of the disease) priority medicines for europe and the world, warren kaplan and richard laing, world health organisation, department of essential drugs ...

  • Industries: Drug and Medication
  • Countries: World, United Kingdom

Company Report: Drug and Medication in The United States for Year 2014

  • Company report
  • April 2014
  • 29 pages

... In glennerster et al. (2006), There are two important market distortions that have resulted in underinvestment of new vaccines for ntds. First, there is a collective action problem; since the bene t of a new ...

  • Industries: Drug and Medication
  • Countries: United States

Drug and Medication Sector in The United States and Australia

  • Industry report
  • March 2014
  • 33 pages
  • by Corporation

... To serious infections and malignancy costs of current anti-tnf drug treatments are approximately $18-30k / year infliximab (remicade ) has been shown to have anti-map activity * hanauer at al ...

  • Industries: Drug and Medication
  • Countries: World, United States, Australia

Drug and Medication Market in The United Kingdom

  • Industry report
  • March 2014
  • 40 pages

... Indications (no details in core guidance) to provide options for clinical development of antibacterial agents to address unmet need important features of core guidance - eu if the pk/pd analyses ...

  • Industries: Drug and Medication
  • Countries: World, United Kingdom

GlaxoSmithKline - Company Report for Year 2014

  • Company report
  • March 2014
  • 27 pages
  • by Corporation

... Approval for january 2014 company drug therapeutic area innovator company generic version of cipla fluconazole capsules anti-infective roerig diflucan aurobindo pharma didanosine capsules anti ...

  • Industries: Drug and Medication
  • Countries: India

Drug and Medication Market Brief

  • Industry report
  • March 2014
  • 17 pages

... Hg introduces new recommendations designed to promote safer use of angiotensin converting enzyme inhibitors (aceis) and angiotensin receptor blockers (arbs) first-line and later-line treatment should now ...

  • Industries: Drug and Medication

Company Report: Drug and Medication for Year 2014

  • Company report
  • March 2014
  • 10 pages

... Ping, the drugs trade and arms trafficking.6 The illicit trade related to hazardous waste as well as to the illegal harvesting of natural resources, par- ticularly timber and fish, has been ...

  • Industries: Drug and Medication
  • Countries: Europe, World

Company Report: Drug and Medication for Year 2014

  • Company report
  • March 2014
  • 24 pages
  • Industries: Drug and Medication

The Canadian Drug Market : Innovation and Technology Trends

  • Industry report
  • March 2014
  • 35 pages
  • Industries: Drug and Medication
  • Countries: Canada

GlaxoSmithKline - Company Report for Year 2014

  • Company report
  • March 2014
  • 27 pages
  • by Corporation
  • Industries: Drug and Medication
  • Countries: India

Company Report: Drug and Medication in The United States for Year 2014

  • Company report
  • March 2014
  • 16 pages
  • Industries: Drug and Medication
  • Countries: United States

Drug and Medication Sector in India

  • Industry report
  • March 2014
  • 35 pages

... Patients in to three catagories: a) the lower income group will get the drug free. B) the middle income patients will be eligible for discount on the full price. C) the rich patients will be asked to pay ...

  • Industries: Drug and Medication
  • Countries: India

Kenya: Demographic Analysis, 2014-2017

  • Country report
  • March 2014
  • 94 pages
  • Industries: Drug and Medication
  • Countries: Kenya

Global Vaccine Production and Trade Statistics

  • Industry report
  • March 2014
  • 36 pages
  • by Intergovernmental Agency

... Have acted as sharp reminders of the omnipresent threat posed by influenza viruses to the health and social and economic well-being of the global population. vaccines remain one of our best defence ...

  • Industries: Drug and Medication
  • Countries: World

Company Report: Vaccine in South Korea for Year 2014

  • Company report
  • March 2014
  • 3 pages

... And commercialization of a preventative pneumococcal disease vaccine. As part of the agreement, sanofi will make an up-front payment of $23 million usd to sk chemical co. Both companies will co ...

  • Industries: Drug and Medication
  • Countries: South Korea

Cedarburg Pharmaceuticals Inc. - Company Report for Year 2014

  • Company report
  • March 2014
  • 2 pages

... The royalties payable under the allegra license agreements; the risk that clients may terminate or reduce demand under any strategic or multi-year deal; the company s ability to enforce its intellectual ...

  • Industries: Drug and Medication
  • Countries: United States

World Vaccine Business Overview

  • Industry report
  • March 2014
  • 22 pages
  • by Intergovernmental Agency

... vaccination 1988: before the global polio eradication initiative endemic non-endemic who. Global polio eradication initiative. Available at: http ...

  • Industries: Drug and Medication
  • Countries: World

Vaccine : Innovation and Technology Trends

  • Industry report
  • March 2014
  • 13 pages
  • by Intergovernmental Agency
  • Industries: Drug and Medication

Drug and Medication Sector in Tanzania, Kenya and Ghana

  • Industry report
  • March 2014
  • 18 pages
  • by Intergovernmental Agency
  • Industries: Drug and Medication
  • Countries: Tanzania, Kenya, Ghana

World Medicine : Innovation and Technology Trends

  • Industry report
  • March 2014
  • 42 pages
  • by Intergovernmental Agency

... External reference pricing (erp) middle income countries ask for a reduced price as well 34 4.4 Eu instruments contributing to global drug development, safety, quality and efficacy access to medicines ...

  • Industries: Drug and Medication
  • Countries: World

World Medicine : Innovation and Technology Trends

  • Industry report
  • March 2014
  • 27 pages
  • by Intergovernmental Agency
  • Industries: Drug and Medication
  • Countries: World

Drug and Medication in The United States : Sector Overview and Key Players

  • Industry report
  • March 2014
  • 15 pages
  • Industries: Drug and Medication
  • Countries: United States

» Purchase Premium Reports (From $ 55 - $ 12 375)

About 5 000 reports
Oncology Drug Pathway Analyzer (Premium Version)

Oncology Drug Pathway Analyzer (Premium Version)

  • $ 14 850
  • Industry report
  • March 2014
  • by Bioseeker

EXTRA: Free online updates for a year Get instant, interactive pathway modeling on more than 3,400 cancer drugs across more than 100 different cancer types. Drug targets and their pathways are the critical ...


» Read our Company Profiles

26 Companies

EDGAR Online Inc.

United States

GlaxoSmithKline P.L.C.

United States

Pfizer Inc.

United States

Johnson and Johnson

United States

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.